&w=3840&q=100)
Concord Biotech share price pops 6% on healthy Q4 nos; profit zooms 48% YoY
Concord Biotech share price: Shares of biopharmaceutical company Concord Biotech were in demand on the last trading day of the week i.e. Friday, with the scrip rallying up to 5.64 per cent to an intraday high of ₹1,761 per share.
By 10:10 AM, Concord Biotech share price was off day's high but continued to trade higher, up 4.43 per cent higher at ₹1,740.75. In comparison, BSE Sensex was down 0.13 per cent at 81,527.12 levels.
Why did Concord Biotech share price rise?
Concord Biotech share price rose on the back of a healthy March quarter of financial year 2025 (Q4FY25) results.
The company's profit climbed 47.8 per cent year-on-year (Y-o-Y) to ₹140 crore in the March quarter of FY25, from ₹95 crore in the March quarter of FY24.
Concord Biotech's revenue from operations surged 34.8 per cent Y-o-Y to ₹429.9 crore in Q4FY25, from ₹319 crore in the same quarter a year ago.
At the operating level, the company's earnings before interest, tax, depreciation and amortisation (Ebitda) zoomed 41.8 per cent Y-o-Y to ₹190.4 crore versus ₹134.3 crore a year ago.
Concord Biotech dividend
The Board has recommended a dividend of ₹10.70 per equity share of face value of ₹1 each fully paid up for FY25, subject to approval by shareholders of the Company at the ensuing AGM.
About Concord Biotech
Concord Biotech, founded in 2000, is a research-driven biopharmaceutical company specialising in the production of Active Pharmaceutical Ingredients (APIs) through fermentation and semi-synthetic processes, along with finished formulations.
Initially a single-product entity, Concord has evolved into a comprehensive solutions provider, offering a broad range of products across various therapeutic segments. The company has established a global presence, distributing its products in over 70 countries, including key markets like the USA, Europe, Japan, and Latin America, while also maintaining a major footprint in India.
Through strategic partnerships with leading global pharmaceutical firms, Concord continues to expand its reach and product offerings in both APIs and finished formulations.
The Dholka facility, established in 2000, focuses on API production and has earned numerous regulatory certifications, including from USFDA, EUGMP, and PMDA.
The Valthera facility, launched in 2016, manufactures a wide range of oral solids and liquids, with plans to expand into injectable formulations.
The newest addition, the Limbasi facility, established in 2021, is dedicated to API production, with advanced capabilities in fermentation and downstream processing.
The market capitalisation of Concord Biotech is ₹18,682 crore, according to BSE. The company falls under the BSE 500 category.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Indian Express
an hour ago
- New Indian Express
Hyundai, Kia offload Ola Electric stakes via block deals
South Korean automakers - Hyundai Motor and Kia Corporation - have divested their entire shareholding in Ola Electric Mobility through block deals, marking a strategic exit from the loss-making electric two-wheeler manufacturer. Hyundai sold 10.8 crore shares at Rs 50.70 apiece, amounting to Rs 552 crore, while Kia sold 2.7 crore shares at Rs 50.55 each, amounting to Rs 138 crores, showed NSE bulk deal data. Shares of Ola Electric closed 8.12% lower at Rs 49.33 on the BSE on Tuesday, As of March 2025, BSE data shows that Hyundai held a 2.4% public stake in the company. Citigroup Global Markets Mauritius purchased 8.61 crore shares at Rs 50.55 per share, thus investing ₹437 crore investment in Ola Electric. The exit by Hyundai and Kia comes days after Ola Electric reported that its losses more than doubled to Rs 870 crore in the fourth quarter of financial year 2025 (Q4FY25) as against Rs 416 crore loss reported in the same quarter of last fiscal (Q4FY24). The company's revenue from operations dropped 59.5% year-on-year to Rs 716 crore. The fall in and bottomline and topline performance is primarily attributed to a sharp decline in sales amid increasing competition from legacy players. Vehicle deliveries came down to 51,375 units in Q4FY25 from 115,000 units in Q4FY24. The company, however, claims to have retained market leadership for FY25, with full-year deliveries coming at 359,000 units, up from 329,000 a year earlier.
Mint
3 hours ago
- Mint
Yes Bank bulk deal: Carlyle group sells 2.6% stake in Yes Bank for ₹1,775 crore; stock down 10%
Global investment firm Carlyle group on Tuesday sold a 2.6 per cent stake in private sector lender Yes Bank for ₹ 1,775 crore through open market transactions. The development comes after State Bank of India and seven other lenders last month announced that they will sell 20 per cent of their combined stake in Yes Bank to Japan's Sumitomo Mitsui Banking Corporation for ₹ 13,483 crore. US-based Carlyle, through its affiliate CA Basque Investments, sold a total of 82 crore shares, representing a 2.62 per cent stake in Mumbai-based Yes Bank on the NSE and BSE, as per the bulk deal data on the bourses. The shares were disposed in the price range of ₹ 21.61-21.68 apiece, taking the combined transaction value to ₹ 1,774.89 crore. After the share sale, Carlyle's arm CA Basque Investments' holding in Yes Bank declined to 4.22 per cent from 6.84 per cent. Details of the buyers of Yes Bank's shares could not be ascertained on the BSE and the National Stock Exchange (NSE). Shares of Yes Bank declined 10.40 per cent to close at ₹ 20.85 apiece on the BSE, and it fell 10.01 per cent to settle at ₹ 20.95 per piece on the NSE. Last month, SBI and seven other lenders announced that they will sell 20 per cent of their combined stake in Yes Bank to Japan's SMBC for a consideration of ₹ 13,483 crore, making it the largest cross-border investment in the Indian banking sector. Following the completion of the transaction, SMBC will become the single-largest shareholder of Mumbai-based Yes Bank. Of the 20 per cent stake, SBI will dilute a 13.19 per cent stake in Yes Bank in favour of SMBC for a consideration of ₹ 8,889 crore, while 6.81 per cent shareholding will be offloaded by seven other lenders, including Axis Bank, Bandhan Bank, Federal Bank, HDFC Bank, ICICI Bank, IDFC First Bank and Kotak Mahindra Bank for about ₹ 4,594 crore. SBI and the seven investor lenders had invested in the bank as part of the YES Bank Reconstruction Scheme in March 2020. Mumbai-headquartered SBI, which owned a 24 per cent stake in Yes Bank, will be left with a little over 10 per cent stake after the dilution. SMBC is a wholly-owned subsidiary of Sumitomo Mitsui Financial Group, Inc (SMFG). SMFG is the second largest banking group in Japan with total assets of USD 2 trillion as of December 2024 with strong global presence. For the fourth quarter ended March 2025, Yes Bank reported a 63 per cent jump in standalone net profit at ₹ 738 crore as compared to ₹ 451.9 crore in the corresponding quarter a year ago.
The Print
5 hours ago
- The Print
Adani Group stocks decline; Adani Ports fall over 2 pc
In a stock exchange filing, the group said reports of links between any of its entities and Iranian LPG are 'baseless and mischievous'. Adani Group on Monday said it does not handle any cargo coming from Iran or any Iranian-owned ship at any of its ports, as it denied any deliberate engagement in sanctions evasion. New Delhi, Jun 3 (PTI) Adani Group stocks ended lower on Tuesday, with Adani Ports, NDTV and Adani Energy falling over 2 per cent each. The filing was in response to a Wall Street Journal (WSJ) report that said US prosecutors were investigating if Adani group companies imported Iranian LPG into India through their Mundra port in Gujarat. Shares of Adani Ports dropped 2.42 per cent, NDTV fell by 2.25 per cent, Adani Energy Solutions declined 2.18 per cent, Adani Power skidded 2.02 per cent and Adani Enterprises went lower by 1.89 per cent on the BSE. The stocks of Adani Total Gas edged lower by 1.62 per cent, Adani Green slipped 1.58 per cent, Sanghi Industries Ltd (1.16 per cent), Ambuja Cements (0.88 per cent), ACC (0.22 per cent) and AWL Agri Business (0.06 per cent). In intra-day trade, NDTV tanked 4.92 per cent, Sanghi Industries dropped 3.44 per cent, Adani Ports fell by 2.77 per cent, Adani Power lost 2.69 per cent, Adani Enterprises went lower by 2.63 per cent, Adani Energy (2.35 per cent), Adani Total (2.10 per cent), Adani Green (2 per cent), Ambuja Cements (1.21 per cent), AWL Agri (1.14 per cent) and ACC (0.62 per cent). In the equity market, the 30-share BSE Sensex tanked 636.24 points or 0.78 per cent to settle at 80,737.51. The NSE Nifty plunged 174.10 points or 0.70 per cent to 24,542.50. 'By policy, the Adani Group does not handle any cargo from Iran at any of our ports. This includes any shipments originating from Iran or any vessels operating under the Iranian flag,' the conglomerate said in the filing. It went on to state that the group 'does not manage or facilitate any ships whose owners are Iranian. This policy is strictly adhered to across all our ports'. The WSJ report claimed that its investigation had found tankers travelling between Mundra and the Persian Gulf exhibited traits experts say are common for ships evading sanctions. Purchase of Iranian oil or products is sanctioned over Tehran's suspected nuclear programme. Calling the report 'baseless and mischievous', the Adani group said it 'categorically denies any deliberate engagement in sanctions evasion or trade involving Iranian-origin LPG'. It went on to add that it was 'not aware of any investigation by US authorities on this subject'. The report, it said, 'appears to be based entirely on incorrect assumptions and speculation'. PTI SUM DR This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.
